M. Iashvili Children’s Central Hospital runs a dedicated focus on rare diseases, with a team studying neuromuscular pathologies such as progressive muscular dystrophy and spinal muscular atrophy. Of three available medications for these conditions, two were first administered in Georgia at this hospital.
The program is delivered through the Center for Neurology, Neurosurgery and Psychiatry and combines genetic, neurological and rehabilitative input for children aged 0 to 18.
What's good
- First in Georgia to administer key rare-disease therapies
- Multidisciplinary genetic and neurological team
Trade-offs
- Therapy availability may be limited
- Pricing and funding details not published online
